BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Brain cancer AND NTRK1, ENSG00000198400, 4914, P04629, TRK1, MTC, DKFZp781I14186, p140-TrkA, TRKA, TRK
323 results:

  • 1. [PET/CT with 11C-methionine in assessment of brain glioma metabolism].
    Vikhrova NB; Kalaeva DB; Tyurina AN; Belyaev AY; Danilov GV; Pronin IN
    Zh Vopr Neirokhir Im N N Burdenko; 2024; 88(1):63-69. PubMed ID: 38334732
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Breaking NGF-trka immunosuppression in melanoma sensitizes immunotherapy for durable memory T cell protection.
    Yin T; Wang G; Wang L; Mudgal P; Wang E; Pan CC; Alexander PB; Wu H; Cao C; Liang Y; Tan L; Huang D; Chong M; Chen R; Lim BJW; Xiang K; Xue W; Wan L; Hu H; Loh YH; Wang XF; Li QJ
    Nat Immunol; 2024 Feb; 25(2):268-281. PubMed ID: 38195702
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Malignant peripheral nerve sheath tumor (MPNST) and MPNST-like entities are defined by a specific DNA methylation profile in pediatric and juvenile population.
    Patrizi S; Miele E; Falcone L; Vallese S; Rossi S; Barresi S; Giovannoni I; Pedace L; Nardini C; Masier I; Abballe L; Cacchione A; Russo I; Di Giannatale A; Di Ruscio V; Salgado CM; Mastronuzzi A; Ciolfi A; Tartaglia M; Milano GM; Locatelli F; Alaggio R
    Clin Epigenetics; 2024 Jan; 16(1):9. PubMed ID: 38178234
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Kinase expression in angiomatoid fibrous histiocytoma: pantrk is commonly expressed in the absence of
    Vargas AC; Joy C; Maclean FM; Bonar F; Wong DD; Gill AJ; Cheah AL
    J Clin Pathol; 2024 Mar; 77(4):251-254. PubMed ID: 38053271
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. CEST and nuclear Overhauser enhancement imaging with deep learning-extrapolated semisolid magnetization transfer reference: Scan-rescan reproducibility and reliability studies.
    Heo HY; Singh M; Yedavalli V; Jiang S; Zhou J
    Magn Reson Med; 2024 Mar; 91(3):1002-1015. PubMed ID: 38009996
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Design, synthesis and anticancer evaluation of novel arylhydrazones of active methylene compounds.
    Murugesan A; Konda Mani S; Koochakkhani S; Subramanian K; Kandhavelu J; Thiyagarajan R; Gurbanov AV; Mahmudov KT; Kandhavelu M
    Int J Biol Macromol; 2024 Jan; 254(Pt 3):127909. PubMed ID: 37951450
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. RBFOX2 recognizes N
    Dou X; Xiao Y; Shen C; Wang K; Wu T; Liu C; Li Y; Yu X; Liu J; Dai Q; Pajdzik K; Ye C; Ge R; Gao B; Yu J; Sun S; Chen M; Chen J; He C
    Nat Cell Biol; 2023 Sep; 25(9):1359-1368. PubMed ID: 37640841
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. [Tyrosine kinase receptor gene fusion: A series of four cases of infantile-type hemispheric glioma].
    Sourty B; Basset L; Michalak S; Colin E; Zidane-Marinnes M; Delion M; de Carli E; Rousseau A
    Ann Pathol; 2023 Nov; 43(6):462-474. PubMed ID: 37635016
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. High-grade glioma in infants and young children is histologically, molecularly, and clinically diverse: Results from the SJYC07 trial and institutional experience.
    Chiang J; Bagchi A; Li X; Dhanda SK; Huang J; Pinto SN; Sioson E; Dalton J; Tatevossian RG; Jia S; Partap S; Fisher PG; Bowers DC; Hassall TEG; Lu C; Zaldivar-Peraza A; Wright KD; Broniscer A; Qaddoumi I; Upadhyaya SA; Vinitsky A; Sabin ND; Orr BA; Klimo P; Boop FA; Ashford JM; Conklin HM; Onar-Thomas A; Zhou X; Ellison DW; Gajjar A; Robinson GW
    Neuro Oncol; 2024 Jan; 26(1):178-190. PubMed ID: 37503880
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. Recent advances in the discovery of tropomyosin receptor kinases trks inhibitors: A mini review.
    El-Nassan HB; Al-Qadhi MA
    Eur J Med Chem; 2023 Oct; 258():115618. PubMed ID: 37413881
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. A comprehensive analysis of infantile central nervous system tumors to improve distinctive criteria for infant-type hemispheric glioma versus desmoplastic infantile ganglioglioma/astrocytoma.
    Tauziède-Espariat A; Beccaria K; Dangouloff-Ros V; Sievers P; Meurgey A; Pissaloux D; Appay R; Saffroy R; Grill J; Mariet C; Bourdeaut F; Hasty L; Métais A; Chrétien F; Blauwblomme T; Puget S; Boddaert N; Varlet P;
    Brain Pathol; 2023 Sep; 33(5):e13182. PubMed ID: 37349135
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. Clinical characteristics, treatment, and long-term outcome of patients with brain metastases from thyroid cancer.
    Wolff L; Steindl A; Popov P; Dieckmann K; Gatterbauer B; Widhalm G; Berghoff AS; Preusser M; Raderer M; Kiesewetter B
    Clin Exp Metastasis; 2023 Jun; 40(3):217-226. PubMed ID: 37219741
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. Head-to-Head Comparison of [
    Ballal S; Yadav MP; Roesch F; Raju S; Satapathy S; Sheokand P; Moon ES; Martin M; Awarwal S; Tripathi M; Bal C
    Thyroid; 2023 Aug; 33(8):974-982. PubMed ID: 37171126
    [No Abstract]    [Full Text] [Related]  

  • 14. LOGGIC Core BioClinical Data Bank: Added clinical value of RNA-Seq in an international molecular diagnostic registry for pediatric low-grade glioma patients.
    Hardin EC; Schmid S; Sommerkamp A; Bodden C; Heipertz AE; Sievers P; Wittmann A; Milde T; Pfister SM; von Deimling A; Horn S; Herz NA; Simon M; Perera AA; Azizi A; Cruz O; Curry S; Van Damme A; Garami M; Hargrave D; Kattamis A; Kotnik BF; Lähteenmäki P; Scheinemann K; Schouten-van Meeteren AYN; Sehested A; Viscardi E; Wormdal OM; Zapotocky M; Ziegler DS; Koch A; Hernáiz Driever P; Witt O; Capper D; Sahm F; Jones DTW; van Tilburg CM
    Neuro Oncol; 2023 Nov; 25(11):2087-2097. PubMed ID: 37075810
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. Optimization of workflow for detection of brain metastases at 3T: is a black-blood mtc prepared 3D T1 used alone robust enough to replace the combination of conventional 3D T1 and the black-blood 3D T1 mtc?
    Chkili S; Lefebvre Y; Chao SL; Bali MA; Lemort M; Coquelet N
    Neuroradiology; 2023 Jul; 65(7):1133-1141. PubMed ID: 36995375
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. Glioneuronal tumor with ATRX alteration, kinase fusion and anaplastic features (GTAKA): a molecularly distinct brain tumor type with recurrent Ntrk gene fusions.
    Bogumil H; Sill M; Schrimpf D; Ismer B; Blume C; Rahmanzade R; Hinz F; Cherkezov A; Banan R; Friedel D; Reuss DE; Selt F; Ecker J; Milde T; Pajtler KW; Schittenhelm J; Hench J; Frank S; Boldt HB; Kristensen BW; Scheie D; Melchior LC; Olesen V; Sehested A; Boué DR; Abdullaev Z; Satgunaseelan L; Kurth I; Seidlitz A; White CL; Ng HK; Shi ZF; Haberler C; Deckert M; Timmer M; Goldbrunner R; Tauziède-Espariat A; Varlet P; Brandner S; Alexandrescu S; Snuderl M; Aldape K; Korshunov A; Witt O; Herold-Mende C; Unterberg A; Wick W; Pfister SM; von Deimling A; Jones DTW; Sahm F; Sievers P
    Acta Neuropathol; 2023 May; 145(5):667-680. PubMed ID: 36933012
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. Neurotrophin mimetics and tropomyosin kinase receptors: a futuristic pharmacological tool for Parkinson's.
    J JB; Palathoti N; Dhanasekaran M; Sivasamy R; Ponnusankar S; Dhanabal SP; Sankar V; Justin A
    Neurol Sci; 2023 Jul; 44(7):2265-2275. PubMed ID: 36870001
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. The phosphorylation of PHF5A by trka-ERK1/2-ABL1 cascade regulates centrosome separation.
    Song C; Zhang Y; Li Y; Bie J; Wang Z; Yang X; Li H; Zhu L; Zhang T; Chang Q; Luo J
    Cell Death Dis; 2023 Feb; 14(2):98. PubMed ID: 36759599
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. Paediatric-type diffuse high-grade gliomas in the 5th CNS WHO Classification.
    Gianno F; Giovannoni I; Cafferata B; Diomedi-Camassei F; Minasi S; Barresi S; Buttarelli FR; Alesi V; Cardoni A; Antonelli M; Puggioni C; Colafati GS; Carai A; Vinci M; Mastronuzzi A; Miele E; Alaggio R; Giangaspero F; Rossi S
    Pathologica; 2022 Dec; 114(6):422-435. PubMed ID: 36534421
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. NVL-520 Is a Selective, trk-Sparing, and brain-Penetrant Inhibitor of ROS1 Fusions and Secondary Resistance Mutations.
    Drilon A; Horan JC; Tangpeerachaikul A; Besse B; Ou SI; Gadgeel SM; Camidge DR; van der Wekken AJ; Nguyen-Phuong L; Acker A; Keddy C; Nicholson KS; Yoda S; Mente S; Sun Y; Soglia JR; Kohl NE; Porter JR; Shair MD; Zhu V; Davare MA; Hata AN; Pelish HE; Lin JJ
    Cancer Discov; 2023 Mar; 13(3):598-615. PubMed ID: 36511802
    [TBL] [Abstract] [Full Text] [Related]  


    [Next]

    of 17.